Warren Buffett famously said, 'Volatility is far from synonymous with risk.' So it seems the smart money knows that debt - which is usually involved in bankruptcies - is a very important factor, when ...

EXTON, Penn. and SAN DIEGO, Oct. 06, 2021 (GLOBE NEWSWIRE) -- Recro Pharma, Inc. (“Recro”; NASD: REPH), a contract development and manufacturing organization (CDMO) dedicated to solving complex ...

With manufacturing operations already locked up in Georgia, Recro Pharma is taking its CDMO ambitions coast-to-coast. Recro has dished out nearly $50 million to acquire CDMO peer Irisys. The deal for ...

President Donald Trump in March said he was considering suing drug companies fueling the opioid crisis — and Congress will allocate $6 billion in new funding over the next two years to advance the ...

MALVERN, Pa., March 04, 2019 (GLOBE NEWSWIRE) -- Recro Pharma, Inc. (NASDAQ:REPH), a revenue generating specialty pharmaceutical company focused on therapeutics for hospitals and other acute care ...

(RTTNews) - Shares of Recro Pharma, Inc. (REPH) are down more than 24% Wednesday morning. This, despite healthcare stocks surging after the results of the Super Tuesday primaries for the Democratic ...

MALVERN, Pa., April 03, 2019 (GLOBE NEWSWIRE) -- Recro Pharma, Inc. (Nasdaq:REPH), a revenue generating specialty pharmaceutical company with a high-performing contract development and manufacturing ...

Recro Pharma ($REPH) had to dial down its asking price and amp up its offering, but the Malvern, PA, biotech managed to go public at last, grossing $30 million to ...

Good morning, and welcome to Recro's third-quarter 2020 financial results conference call. [Operator instructions] As a reminder, this conference call is being recorded at the company's request. I ...

Hedge funds are not perfect. They have their bad picks just like everyone else. Facebook, a stock hedge funds have loved dearly, lost nearly 40% of its value at one point in 2018. Although hedge funds ...

Case Name: Recro Gainesville LLC v. Actavis Labs. FL, Inc., Civ. No. 14-1118-GMS, 2017 U.S. Dist. LEXIS 24428 (D. Del. Feb. 22, 2017) (Sleet, J.) Drug Product and U.S ...